Ampullary Adenoma
Review lesions at the bile and pancreatic duct opening.
Learn MoreDuodenal polyp diagnosis reviews size, location, appearance, symptoms, endoscopy, imaging, and biopsy findings. GastroDoxs GutSignal Decode™ helps determine polyp type, cancer risk, and whether monitoring, removal, or treatment is needed.
4.7 · 1,900+ Reviews
Duodenal polyps include non-neoplastic lesions, adenomas, glandular growths, hamartomas, neuroendocrine tumors, and other subepithelial lesions. GastroDoxs GutSignal Decode™ helps patients connect upper-endoscopy appearance, biopsy findings, lesion size, duodenal segment, proximity to the ampulla, dysplasia, and family history into a precise diagnostic plan.
The endoscopy report should describe the lesion’s size, morphology, suspected mucosal or subepithelial origin, orientation, and relationship to the major and minor papillae.
Pathology is central because many benign lesions can resemble adenomas visually. Adenomatous tissue requires special attention because it has malignant potential and often leads to a resection discussion.
Additional EUS, side-viewing endoscopy, duct imaging, colonoscopy, or genetic assessment may be needed when the lesion is near the ampulla, appears deep, is large, is multiple, or occurs with a polyposis pattern.
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
Your answers. GastroDoxs GutSignal Decode™ cracks your body's distress codes - delivering expert gastroenterologist interpretation of your GI symptoms, lab results, endoscopy findings, conditions, and digestive imaging across the full spectrum of digestive disease - translating every signal your gut sends into a confirmed diagnosis and a clear, board-certified plan of attack built entirely around you.
| Finding or Pattern | Why It Matters | Possible Next Step |
|---|---|---|
| Small non-neoplastic lesion without dysplasia | May not require resection unless symptomatic or bleeding | Pathology correlation and individualized follow-up |
| Sporadic nonampullary duodenal adenoma | Carries malignant potential but resection also has meaningful risk | Advanced endoscopic resection planning and surveillance |
| Periampullary, subepithelial, large, or invasive-appearing lesion | May involve ducts or deeper wall layers | Side-viewing exam, EUS, multidisciplinary review, or surgery |
GastroDoxs evaluates duodenal polyps using endoscopic mapping, pathology, dysplasia, lesion size, relationship to the papilla, symptoms, comorbidities, and inherited risk.
The plan may involve observation, repeat endoscopy, advanced endoscopic resection, EUS, side-viewing examination, colonoscopy, genetic assessment, surgery, or oncology care.
This duodenal polyp diagnosis guide is written for patient education and reviewed for digestive-health accuracy.
Duodenal resection carries higher bleeding and perforation risk than routine colon-polyp removal. Decisions should balance malignant potential against procedure risk and available expertise.
Duodenal Polyp evaluation at GastroDoxs is guided by experienced digestive specialists who help connect symptoms, testing, and next-step care.
The patient is concerned about duodenal polyp but is not sure what the diagnosis means or which symptoms matter.
Symptoms, risk factors, lab results, imaging, or prior findings begin to show a pattern that needs medical interpretation.
A GI evaluation helps review history, warning signs, possible causes, and whether testing or referral is needed.
The gastroenterologist connects symptoms, test results, and clinical findings to explain the most appropriate next step.
The patient leaves with a clearer plan for monitoring, treatment, testing, referral, or follow-up care.
A gastroenterologist usually identifies the lesion during upper endoscopy and documents its size, shape, location, surface, relation to the ampulla, and signs of bleeding or obstruction. Biopsy or resection pathology establishes the tissue type and dysplasia grade.
Evaluation may include EGD, targeted biopsy, side-viewing duodenoscopy, EUS, CT or MRI, laboratory testing for anemia or biliary obstruction, colonoscopy, and genetic assessment when inherited polyposis is possible.
EGD directly visualizes the duodenum and allows high-definition inspection, photography, measurement, biopsy, and treatment planning. It also shows whether the lesion is near the papilla, ulcerated, bleeding, or causing narrowing.
Biopsy helps distinguish an adenoma from inflammatory, glandular, hamartomatous, neuroendocrine, or other lesions and grades dysplasia. Sampling strategy is individualized because prior biopsy can create scarring that may complicate later endoscopic resection.
They combine endoscopic appearance with pathology. Adenomatous histology and dysplasia indicate neoplastic potential, while size, villous features, surface irregularity, ulceration, nonlifting, and suspected invasion influence risk.
Important factors include histology, dysplasia, size, morphology, location, ampullary involvement, number of lesions, symptoms, inherited syndromes, patient health, endoscopic expertise, and the risks of bleeding or perforation.
Endoscopic resection is commonly considered for nonampullary duodenal adenomas without evidence of deep invasion when removal can be performed safely. Very small low-risk lesions, complex ampullary disease, or suspected cancer may follow different pathways.
The specimen is reviewed by pathology for histologic type, dysplasia, invasive cancer, and resection margins when assessable. The endoscopy report documents whether removal was en bloc or piecemeal and whether residual tissue or immediate complications were present.
Follow-up endoscopy checks for residual or recurrent tissue and examines the resection site. The interval depends on pathology, completeness of removal, lesion size, piecemeal resection, inherited risk, and findings at the first surveillance examination.
Yes. Residual tissue may remain after piecemeal removal, and recurrence can develop at the resection site. Patients with polyposis syndromes may also form additional lesions elsewhere in the duodenum.
Adenomas may enlarge and develop higher-grade dysplasia or cancer. Other lesions may bleed, cause anemia, obstruct food passage, or affect the bile and pancreatic ducts depending on size and location.
Management targets the lesion and the consequence it causes. Bleeding may require endoscopic hemostasis or resection, anemia may need iron replacement, obstruction may require advanced endoscopic or surgical care, and biliary symptoms may require pancreaticobiliary evaluation.
EUS, CT, or MRI may be needed when the lesion is subepithelial, large, near the ampulla, possibly invasive, associated with jaundice or pancreatitis, or not fully characterized by standard endoscopy.
Risk assessment integrates pathology, dysplasia, size, villous architecture, endoscopic morphology, growth, ampullary or duct involvement, invasion signs, multiplicity, family history, and inherited polyposis.
Seek specialist review after an imaging or endoscopy report identifies a duodenal lesion, especially with dysplasia, anemia, black stool, vomiting, weight loss, jaundice, multiple polyps, or family-history concerns. Major bleeding or severe post-procedure pain requires urgent care.
Bring your symptom timeline, laboratory results, imaging, procedure reports, medicines, and prior records for a focused review. GastroDoxs can help determine the most appropriate diagnostic and follow-up pathway.